Contact us
 |
[email protected] |
 |
3275638434 |
 |
 |
| Paper Publishing WeChat |
Useful Links
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Article
Circular Economy in HealthCare Challenges and Issues
Author(s)
Christine C Huttin
Full-Text PDF
XML 229 Views
DOI:10.17265/2328-2185/2023.04.005
Affiliation(s)
Aix Marseille University, Marseille, France
ENDEPUSresearch, Cambridge, USA
ABSTRACT
Some major countries like India investing in biopharmaceutical industry have designed new business models of circular economics called the “Uber for HealthCare” for instance by Basu et al., for medical equipment in India (Euro, Healthcare Stream, & Dublin 2018). This raises major challenges for global supply of medicine and Value Chains in life science. This contribution will provide a review of recent experiences and an analysis of how it impacts current global value chains. Current economic model development strengthening the demand side of the system and applications of choice modeling to capture heterogeneity of demand at individual level face with new circular strategies implemented by health care organizations and economic suppliers. The all-value system is challenged by such models including the critical decision points at prognostic, diagnostic, and treatment stages; platforms such as the Her2adaptive technology platform with cost sensitivity indexes proposed by Huttin and Liebman (Technology & HealthCare, 2011) face also potential adaptation to integrate new priorities: for instance, in circular economy with integration of circular touch points. Research results like Van Boerdonk et al. (2021), demonstrate that reaching cleaner production with higher environmental values may become “paradoxical with lower or unimportant customer value”. Government and payers may need to create new policies for waste management and for sustaining reasonable and fair value for money in the health system. Moreover, the economics of sharing economy may need to find appropriate forms of centralization or decentralization in the organizations of health systems and decision-making processes. Circular models in health care in sharing economy may benefit single pathway models, often too expensive for affordable welfare contracts. This paper will continue the previous research agenda and papers on global value chains with the use of TiVa OECD database (joined in the WB-WTO project) and a quality paper on the biotech development chain and Covid-19 (Huttin, 2019; 2021).
KEYWORDS
circular models, shared economy, health care, global value chains, biotech-life science
Cite this paper
References